image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
c45122e8cce2c4f2b9195209cd589f573953f527ce96a31313375513fd67c2a1.png | simple | <table><tr><td>Group (n = 5)</td><td>Tumor volume(mm<sup>3</sup>)</td><td>Inhibitory Rate (%)</td><td>Tumor weight (g)</td><td>Inhibitory Rate (%)</td></tr><tr><td>control</td><td>2531.78 ± 153.25</td><td></td><td>1.194 ± 0.10</td><td></td></tr><tr><td>Tet (40 mg/kg)</td><td>1243.00 ± 55.19<sup>***</sup>... |
de21fc2f4baca285a5b63fd8e109eb793b2b39ed9d4a807a8f7b583614004899.png | complex | <table><tr><td rowspan="2">Parameter</td><td rowspan="2">Base case (male, female)</td><td>Age 55 years</td><td>Age 60 years</td></tr><tr><td>Threshold</td><td>Threshold</td></tr><tr><td>First aseptic revision rate (early)</td><td>1.31%, 1.13%</td><td>Robust</td><td>Robust</td></tr><tr><td>First aseptic revision rate (l... |
0d5dbbf57c60ff479fb1dc1cca048a73f524b079a64cc00f9b2a5bd210dfebb0.png | complex | <table><tr><td>Characteristics</td><td>Mean (SD)</td><td>n (%)</td></tr><tr><td colspan="3">Gender</td></tr><tr><td>Male</td><td></td><td>162 (47.5)</td></tr><tr><td>Female</td><td></td><td>179 (52.5)</td></tr><tr><td colspan="3">Marital Status</td></tr><tr><td>Single</td><td></td><td>20 (5.9)</td></tr><tr><td>Married<... |
ce5a487e1faf94a0498cdd4b3602a0369c4d73c7ada352958214bc768a537ea3.png | simple | <table><tr><td>Filtering Criteria</td><td>Number of SNPs Excluded</td><td>Number of SNPs Remaining</td></tr><tr><td>None</td><td>0</td><td>2,740,205</td></tr><tr><td>Multiple Variants hits</td><td>33,917</td><td>2,706,288</td></tr><tr><td>Heterozygous and Bias*</td><td>2,111,439</td><td>594,849</td></tr><tr><td>Flankin... |
2889fdaf2c346e44d545495d875e259a9faf162b6d7fde02adb4e4eb691d16b0.png | complex | <table><tr><td></td><td>Total cost</td><td>Medical cost</td><td>Drug cost</td></tr><tr><td colspan="4"><i>Crude cost change – binary indicator</i></td></tr><tr><td> Chronic users</td><td>20,161**(18,775–21,547)</td><td>10,925**(9637–12,213)</td><td>9236**(8841–9632)</td></tr><tr><td> Concomitant... |
c5adf3bcf69d65954db1cbd728582c9325992429f537879df0918c8f5fa1ba9a.png | complex | <table><tr><td></td><td colspan="2">Patients with dementia N = 1059</td><td colspan="2">Comparison patients N = 5543</td></tr><tr><td>Non-Osteoporosis group</td><td>N</td><td>%</td><td>N.</td><td>%</td></tr><tr><td>Total</td><td></td><td></td><td></td><td></td></tr><tr><td>Non-osteoporosis</td><td>177</td><td>16.71</td... |
0cb2651a358636b72adb787701a911dc31c6f53fd0a80e7c585d99c71c4be044.png | complex | <table><tr><td>Congenital Malformation</td><td colspan="5">Count of Exposures</td></tr><tr><td></td><td>Number of dyads</td><td colspan="2">Fathers (max/individual = 3)</td><td colspan="2">Mothers (max/individual = 2)</td></tr><tr><td></td><td></td><td>Cases</td><td>Controls</td><td>Cases</td><td>Controls</td></tr><tr>... |
d7da4b6798480578b76f467e6850b59e9b9edb9879fd62c5d1975fd9c0ce81e5.png | simple | <table><tr><td>Cancer type</td><td>Mechanism</td><td>Agent</td><td>Phase</td></tr><tr><td>Melanoma</td><td>Anti-CTLA-4</td><td>Ipilimumab</td><td>FDA approved</td></tr><tr><td>Melanoma</td><td>Anti-PD-1</td><td>Nivolumab</td><td>Phase III</td></tr><tr><td>Melanoma</td><td>Anti-PD-1</td><td>Pembrolizumab</td><td>FDA app... |
25057fe7d785b93fcdba090dab02521fb9b5040a11fca9ba875e01cc21f18f55.png | simple | <table><tr><td>Item</td><td>Never</td><td>Seldom (< 1/month)</td><td>Occasionally (1 to 3 times/month)</td><td>Often (1 to 2 times/week)</td><td>Frequently (≥3 times/week)</td></tr><tr><td></td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td>N (%)</td></tr><tr><td>Applied to patient care</td><td>0 ... |
48ee398c87dd426524e19b1057848187b1288f4f147b30d140c621880c4929b5.png | simple | <table><tr><td>Drug</td><td>Target</td><td>Rat study standard findings</td><td>Human clinical findings</td><td>MMtox prediction</td></tr><tr><td>Captopril</td><td>Kidney</td><td>Yes</td><td>Yes</td><td>Yes (∗)</td></tr><tr><td>Lisinopril</td><td>Kidney</td><td>Yes</td><td>Yes</td><td>Yes (∗)</td></tr><tr><t... |
bfbdbe365487b672e94af3baa627f765decfa2814e6473b20e23653a9a0fe661.png | simple | <table><tr><td>Test Material/Chemical</td><td>Experimental Model</td><td>Findings</td><td>Reference</td></tr><tr><td>Xanthigen (brown marine algae fucoxanthin + pomegranate seed oil)</td><td>Mouse 3T3-L1 preadipocytes</td><td>↓ accumulation of lipid droplets in adipocytes;↓ protein levels of key adipogenesi... |
a83e195256a896610895f7e6174c004113236875c1245549e5684f63170d3ad6.png | simple | <table><tr><td>Variable</td><td>HR* (95% CI)</td><td>p value </td></tr><tr><td>Age </td><td>1.04 (1.01–1.07)</td><td>0.014</td></tr><tr><td>Loss of Hemoglobin</td><td>1.23 (1.03–1.47)</td><td>0.023</td></tr><tr><td>Biopsy proven rejection</td><td>2.4 (1.41–4.0)</td><td>0.001</td></tr></table> |
1fcba135271590b192a139f71668f35cc0d54a02e0170551e546335dde6712d6.png | simple | <table><tr><td>Scale</td><td>Measures</td></tr><tr><td>Physical Component</td><td></td></tr><tr><td> Physical functioning (PF)</td><td>Limitations in physical activities due to health problems</td></tr><tr><td> Role-physical (RP)</td><td>Limitations in usual daily activities due to health problems</td></tr><tr><td> Bod... |
2b31d19b9dbfc2b5b6a8f7cb34b81bcee9d6b9943eab1d0e6e5810f4e4d9fdfd.png | complex | <table><tr><td rowspan="2">Risk factors</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>HR</td><td>p-value</td><td>95% CI</td><td>HR</td><td>p-value</td><td>95% CI</td></tr><tr><td>Lucat1 expression</td><td>1.155</td><td>0.000<sup>**</sup></td><td>1.082-1.233</td><td>1... |
2da33c0d2fd2ee2094ea12853f89f2a96aaed83978c550d4685036a9bf45f3a8.png | simple | <table><tr><td>Parameters</td><td>Proposed Sensor </td><td>XTE-190</td></tr><tr><td>Operational mode</td><td>Absolute</td><td>Absolute</td></tr><tr><td>Pressure range</td><td>2 MPa</td><td>1.7 MPa</td></tr><tr><td>Compensated temperature range</td><td>+20–220 °C</td><td>+25–232 °C</td></tr><tr><td... |
52fc3b955005ff7269d2d43dd37f0cb10d7f3c3c8496acfe11a1d5ce0dd0390a.png | simple | <table><tr><td>Syntax Score Category</td><td>Low(<22)(n=83)</td><td>Intermediate(23-32)(n=36)</td><td>High(>32) p(n=21)</td><td> p </td></tr><tr><td>Age (years), <i>mean</i><i>Minimum-Maximum</i><i>95% CI</i></td><td>65.843-97(63.6-67.9)</td><td>70.346-87(66.8-73.8)</td><td>66.9 47-83(62.8-71.1)</td><td>0.074</td... |
b56014be0943a2b3573052caacdb23b880fb89f256771c44bc4118af95184080.png | complex | <table><tr><td>Type of cells</td><td colspan="7">Bladder cancer cell line</td></tr><tr><td></td><td>T24</td><td>RT4</td><td>5637</td><td>SW780</td><td>UMUC3</td><td>HT1376</td><td>TSSCUP</td></tr><tr><td>Unsorted</td><td>0/10</td><td>0/10</td><td>0/10</td><td>0/10</td><td>0/10</td><td>0/10</td><td>0/10</td></tr><tr><td... |
854c5449537f03bd83bc493d68728c8ca6c566118946af74f8af3b2e15f1377e.png | complex | <table><tr><td colspan="3">Mechanical incremental steps compression</td></tr><tr><td>Compression factor</td><td>Intraparticle porosity</td><td>Voidage space</td></tr><tr><td>(λ)</td><td>(<i>ε</i><sub><i>p</i></sub>)</td><td>(<i>ε</i>)</td></tr><tr><td>0.00</td><td>0.63</td><td>0.41</td></tr><tr><td>0.02<... |
aa6167aba51afa0f768c57d9b5131559bc245d9e68c39046fb5df9d67feb38f0.png | simple | <table><tr><td>Group</td><td>Treatment</td><td>Sham</td></tr><tr><td>Men/women (number of patients)</td><td>3/17</td><td>4/16</td></tr><tr><td>Age (years)</td><td>43.5 ± 11.07</td><td>43.55 ± 7.82</td></tr><tr><td>Headache history (years)</td><td>15.25 ± 8.37</td><td>18.75 ± 9.98</td></tr><tr><td>Ba... |
b3186c48379ed32a672f1943b75e779ae27c9fc4ea664b52c05712d468524edd.png | complex | <table><tr><td></td><td colspan="8">Furosemide</td><td colspan="8">Placebo</td></tr><tr><td></td><td colspan="4">PEFR</td><td colspan="4">FEV1.0</td><td colspan="4">PEFR</td><td colspan="4">FEV 1.0</td></tr><tr><td>Study (year)</td><td>Baseline airflow</td><td>SD</td><td>Post-treatment airflow</td><td>SD</td><td>Baseli... |
a89fb4e93a51ddd895e9a8b2a9f341cfbb7c4bc12fed90b7065fb8c78883dba5.png | complex | <table><tr><td rowspan="2">Determinants</td><td rowspan="2">Food-hygiene practice</td><td colspan="3">Diarrhea</td></tr><tr><td>%</td><td>Unadjusted OR (95% CI)</td><td>Adjusted<sup>a </sup>OR (95% CI)</td></tr><tr><td>All children</td><td>Poor</td><td>11</td><td>1.15 (0.51–2.60)</td><td>1.33 (0.57–3.14)</t... |
2f04d54bf72318b01443391a31610b1354f3fda883ae295771328c1da536d8f9.png | simple | <table><tr><td>MODEL</td><td>χ<sup>2</sup>/df</td><td>GFI</td><td>AGFI</td><td>NFI</td><td>IFI</td><td>CFI</td><td>RMR</td><td>RMSEA</td></tr><tr><td>Experience value</td><td>2.0-5.0</td><td>>0.90</td><td>>0.90</td><td>>0.90</td><td>>0.90</td><td>>0.90</td><td><0.10</td><td><0.08</td></tr><tr>... |
43af0dc0dbd541fddc8df4911fc337fa2dbf38be8e9f3e2efd1a2ade1c2bd00a.png | complex | <table><tr><td></td><td></td><td colspan="2">Specific Production (μmol/min/mg)</td></tr><tr><td>Substrate</td><td>Product</td><td>Monohydroxy Fatty Acid</td><td>Dihydroxy Fatty Acid</td></tr><tr><td>Palmitoleic acid (16:1<sup>Δ9</sup><i><sup>Z</sup></i>)</td><td>8-HHME</td><td>9.6 ± 0.2</td><td>NA</td></... |
6ec913de21ab3dd18d891840b584b0469d1cf68de560f208865c987584c3d8a9.png | complex | <table><tr><td colspan="2">Up-Regulated Genes</td><td colspan="2">Down-Regulated Genes</td></tr><tr><td>Gene Symbol</td><td>Gene Name</td><td>Gene Symbol</td><td>Gene Name</td></tr><tr><td><i>APOLD1</i></td><td>Apolipoprotein L domain containing 1</td><td><i>AMD1</i></td><td>S-adenosylmethionine decarboxylase 1</td></t... |
91270071125c2ef42f20c89866e12102c2627dc42f444b95578836cdd8d4aaef.png | simple | <table><tr><td>Annotation</td><td>Figure 1A*</td><td><i>S. pneumoniae TIGR4</i></td><td><i>S. pneumoniae </i>G54</td><td><i>S. mitis B6</i></td><td><i>S. oralis Uo5</i></td><td><i>S. gordonii V288</i></td><td><i>S. sanguinis SK36</i></td></tr><tr><td>Regulator</td><td>1</td><td>SP1674</td><td>SPG1583</td><td>smi0612</t... |
6a76394ab013a24dee75bf7487c8f3597c72a868c624f39384346856d7c1dcea.png | simple | <table><tr><td></td><td></td><td>Age (year)</td><td>BMI (kg/m<sup>2</sup>)</td><td>Size of Tumor (mm)</td><td>Number of Tumor</td></tr><tr><td>Urine HER2/neu</td><td>r</td><td>-0.014</td><td>-0.022</td><td>0.277</td><td>-0.057</td></tr><tr><td></td><td>p</td><td>0.897</td><td>0.843</td><td>0.068</td><td>0.711</td></tr>... |
07e7c484abf4f50640825879b15d51fd79dfb72e226f326489d32e83301a3e5b.png | complex | <table><tr><td>sRNA id</td><td>Start</td><td>End</td><td>Length(nucleotides)</td><td>Flanking gene id</td><td>Strand*</td><td>Expression pattern</td><td>Relative copy numbers</td><td colspan="2">Primers</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Start</td><td>End</td></tr><... |
c75814f543e52b3d86271f20f77fa3c079ec3500f8baef4b62bc6194cad5c0da.png | simple | <table><tr><td>Cell line class</td><td>S:MI</td><td>S:MER</td><td>MER:MI</td><td>Significant predictive relationships</td></tr><tr><td>HMEC</td><td><0.0001**</td><td>0.006**</td><td>0.0120*</td><td>S→MER, MER→MI, and S→MI</td></tr><tr><td>BL</td><td>0.5996</td><td>0.5954</td><td>0.1659</td><td>N/A<... |
32d76eaeff27e75b9bb4aa58e6fa7605d0c11a7c032260eedcb192c03cfa6363.png | simple | <table><tr><td></td><td>cluster α</td><td>hybrid</td><td>cluster β</td></tr><tr><td>Lineage 1</td><td>80</td><td>0</td><td>1</td></tr><tr><td>Lineage 2</td><td>22</td><td>7</td><td>82</td></tr></table> |
cd89c283517ebb078cf212b4a1373c7ef988a4539b92fad631c7faf16978ff40.png | simple | <table><tr><td>PCMP Samples</td><td>Sample 1#</td><td>Sample 2#</td><td>Sample 3#</td><td>Sample 4#</td><td>Sample 5#</td><td>Sample 6#</td><td>Sample 7#</td><td>Sample 8#</td><td>Sample 9#</td></tr><tr><td>AP percentage (%)</td><td>0</td><td>2.5</td><td>5</td><td>7.5</td><td>10</td><td>12.5</td><td>15</td><td>17.5</td... |
56a07978eb75aeab525da5e6118328f87e1f85ced2d5a3c6488282185e26cb96.png | complex | <table><tr><td>Guliver coding System</td><td rowspan="2">Total sample</td><td rowspan="2">NL</td><td rowspan="2">IT</td><td rowspan="2">UK</td><td rowspan="2">BE</td></tr><tr><td>Category</td></tr><tr><td>Non-verbal behaviour</td><td>69.1</td><td>74.4</td><td>90.0</td><td>59.0</td><td>62.6</td></tr><tr><td>Structuring<... |
1c4b91f2ae963a7bafdf907aca89697c2b42ff15ef60cd556040649351f8c51c.png | simple | <table><tr><td></td><td>Grade 1</td><td>Grade 2</td><td>Grade 3</td><td>Total</td></tr><tr><td>Group 1</td><td>18 (47.3%)</td><td>15 (39.5%)</td><td>5 (13.2%)</td><td>38</td></tr><tr><td>Group 2</td><td>16 (44.4%)</td><td>13 (36.1%)</td><td>7 (19.4%)</td><td>36</td></tr></table> |
20123052d4310f72cb269ee6f60757e45cfec717b4f8565edf59a400e18f1403.png | complex | <table><tr><td rowspan="2">Characteristic</td><td colspan="2">Boys</td><td colspan="2">Girls</td></tr><tr><td>OR</td><td>95% CI</td><td>OR</td><td>95% CI</td></tr><tr><td>Secondhand Smoke Exposure in Household (/None)</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>1–2 Days</td><td>1.00</td><td>0.88̵... |
99c9829b3e807589228e0a478030ebbae3d35c57fc2aa0eda1ff6b9195848a5e.png | complex | <table><tr><td rowspan="3">Variable</td><td rowspan="2">Placebo (<i>n</i> = 25)</td><td colspan="6">Telotristat ethyl</td></tr><tr><td colspan="3">250 mg tid (<i>n</i> = 25)</td><td colspan="3">500 mg tid (<i>n</i> = 25)</td></tr><tr><td>Mean (s.d.)</td><td>Mean (s.d.)</td><td><i>P</i></td><td>95% CL</td><td>Mean (s.d.... |
f92cd5d011a2ef0b1071124804f603c29631d9a8d72005b4c22c7c16f1636a67.png | simple | <table><tr><td>Performance Statistics</td><td>Total(<i>n</i> = 1053)</td><td>Initial surgery-MR interval ≤ 36 months(<i>n</i> = 709)</td><td>Initial surgery-MR interval > 36 months(<i>n</i> = 344)</td><td><i>p</i> value</td></tr><tr><td>Cancer detection rate for MRI<sup>a</sup></td><td>6.7 (7/1053)</td><td>1.4... |
d2df24024962d4ecb7fc1034267c9387755e791ead3ad2984879ec05b7fe78ae.png | complex | <table><tr><td></td><td>Men</td><td>Women</td><td></td></tr><tr><td></td><td colspan="2">Change from baseline value</td><td><i>P</i> value</td></tr><tr><td>HR (beats/min)</td><td>47 ± 12</td><td>38 ± 10</td><td>0.20</td></tr><tr><td>MAP (mmHg)</td><td>−31 ± 9</td><td>−33 ± 8</td><td>0.45... |
8e298d72c64af258baa9af87aae515ec7961a4043e23b0974a05823bf2c48a92.png | simple | <table><tr><td>Gene Title and Abbreviation (The GENE Database)</td><td>Percent Change </td></tr><tr><td>OPRM1, 1 opioid receptor, mu 1</td><td>+1294</td></tr><tr><td>TP73, 2 tumor protein p73</td><td>+938</td></tr><tr><td>KCND1, 3 potassium voltage-gated channel, Shal-related subfamily, member 1</td><td>+845</td></tr><... |
073de18bfcab82ee45d5b27f77030bf99a6d86c8fcec4c50fcd3de10a51fc411.png | complex | <table><tr><td rowspan="2">Prognostic factor/parameter</td><td rowspan="2">N evt/N pts</td><td colspan="2">Univariate analysis (n=108)</td><td colspan="2">Multivariate analysis (n=99)</td></tr><tr><td>HR [95% CI]</td><td><i>p</i>-Value (Wald)</td><td>HR [95% CI]</td><td><i>p</i>-Value (Wald)</td></tr><tr><td>Smoker sta... |
8e5e8afeff06649aa22209969495d941eb7f46392f243ce483971cc866d9b803.png | complex | <table><tr><td></td><td></td><td colspan="5">Relative risk reduction</td></tr><tr><td></td><td></td><td>20%</td><td>24%</td><td>28%</td><td>32%</td><td>35%</td></tr><tr><td>Control event rate</td><td>25%</td><td>0.49</td><td>0.68</td><td>0.84</td><td>0.93</td><td>0.97</td></tr><tr><td></td><td>27%</td><td>0.54</td><td>... |
e463722e0d61154e0b10b52afa6eec580f0fc6f9a8a7aa29f0f63778d3acdd23.png | simple | <table><tr><td> </td><td>Predicted change in hazard for one unit change in variable</td><td>Significance (<i>P</i>)</td></tr><tr><td>HADS anxiety</td><td>1.012 (0.39–2.58)</td><td>0.98</td></tr><tr><td>HADS depression</td><td>0.82 (0.22–3.05)</td><td>0.76</td></tr><tr><td>PANAS negative affect</td><td>1.07 ... |
6bddfae7be93ecfa85b7b28dd77ad2927644c8071c63bd48da8898650db1e5e9.png | simple | <table><tr><td> </td><td>N</td><td>Minimum</td><td>Maximum</td><td>Mean</td><td>Std. Deviation</td></tr><tr><td>IL- 17 B</td><td>24</td><td>18.258</td><td>31.605</td><td>23.63281</td><td>3.553243</td></tr><tr><td>IL-10 B</td><td>24</td><td>.00</td><td>112.43</td><td>13.8533</td><td>28.72131</td></tr><tr><td>IL-17 P</td... |
20a6135d7fa210053e50836a51f31cc37bec988b3ff31510821e29a02f5860ac.png | simple | <table><tr><td>Author, Year [Reference]</td><td>Study Design</td><td>StudyPopulationParticipantsAgeBMIHealth Status</td><td>Intervention and Doses</td><td>Duration Weeks</td><td>Observed Effects</td></tr><tr><td>Pol, 2013 [28]</td><td>Meta-analysis of 26 RCTs</td><td>2060 M/F18–70 years18.5–35.8 kg/m<sup>2<... |
01948ae250c97faaf24303c7d359e2314a9e1d1246d5543bb168ad3037a5f85e.png | simple | <table><tr><td>Year</td><td>High-risk owned dogs</td><td>Pets</td></tr><tr><td></td><td>Positive/Total (%)</td><td>Positive/Total (%)</td></tr><tr><td>2011</td><td>7/196 (3.6)</td><td>8/811 (1.0)</td></tr><tr><td>2012</td><td>10/502 (2.0)</td><td>9/561 (1.6)</td></tr><tr><td>2013</td><td>10/415 (2.4)</td><td>–</t... |
a112902abfbe0ebc2adcae64cfa2bf09ca52e21f20b1a682ea67d996dbb8cc0b.png | complex | <table><tr><td>Assembler</td><td>Number of scaffolds</td><td>Longest scaffold (kb)</td><td>Longest scaffold corr. (kb)</td><td>N50 (kb)</td><td>Err.</td><td>N50 corr. (kb)</td><td>LAP</td></tr><tr><td colspan="8"><i>Human chromosome 14</i>, starting from Velvet assembly</td></tr><tr><td> Before</td><td>1,081</td><td>4,... |
0c30c092c376aefc9f2daee32d3e146163d61bf02fd6cfe6593927d71e9b102d.png | complex | <table><tr><td></td><td>*1/*1 (n<i> </i>=<i> </i>229)</td><td>*1/*2 + *2/*2 (n<i> </i>=<i> </i>148)</td><td><i>P</i>‐value</td></tr><tr><td>Lesion vessel number</td><td></td><td></td><td>NS</td></tr><tr><td>1 (n, %)</td><td>55 (24%)</td><td>39 (26.4%)</td><td></td></tr><tr><td>2 (n, %)</td><td>69 (30.1%)</td><td>... |
585dfeabbbc24436b2d00e138a97dc781b3588696f202abd6affc92c29f11e39.png | simple | <table><tr><td>Variable</td><td>Possible score range</td><td>Group</td><td>Number</td><td>Baseline Mean (SD)</td><td>Number</td><td>Month 3 Mean (SD)</td><td>Mean change (SD)</td><td><i>t</i>-test (<i>p</i>-value) <sup>a</sup></td></tr><tr><td>Self-management knowledge<sup>b</sup></td><td>0–27</td><td>Interventio... |
79e8eac811b2a1f5719e02ec70367f7e8ee136637cc51a752192f1fdc7f63dc8.png | complex | <table><tr><td>Repeat type</td><td colspan="3">Structured</td><td colspan="3">Unstructured</td></tr><tr><td></td><td>RONN</td><td>DISOPRED</td><td>IUPRED</td><td>RONN</td><td>DISOPRED</td><td>IUPRED</td></tr><tr><td>E</td><td>3</td><td>13</td><td>10</td><td>97</td><td>87</td><td>90</td></tr><tr><td>P</td><td>6</td><td>... |
cf762ac10a009531ba1257fbd813396054efb756f18b4fa31ea0b86fbdab4662.png | complex | <table><tr><td></td><td>Setting</td><td colspan="6">Results of simulations</td></tr><tr><td>Methods (Effect measures)</td><td><i>β</i><sub>X</sub></td><td>Mean of estimates (Ratio scale)</td><td>Bias (Log scale)</td><td>Empirical standard error</td><td>Mean squared error</td><td>Mean standard error</td><td>Coverag... |
fda82e4d7263a1359ee3a36cd925dd498c0f2d17ff27a5e707fe0b09ad37df85.png | simple | <table><tr><td>mRNA</td><td>Primers<sup>a</sup></td></tr><tr><td>MMP-13</td><td>Fw: 5'-TTGGTCAGATGTGACACCTCRv: 5'-ATCGGGAAGCATAAAGTGGC</td></tr><tr><td>Cathepsin K</td><td>Fw: 5'-AGGTGGATGAAATCTCTCGGRv: 5'-TTCTTGAGTTGGCCCTCCAG</td></tr><tr><td>5-LOX</td><td>Fw: 5'-TGCGTTCCAGTGACTTCCACRv: 5'-CTCTGCACCATCTGCACGTG</td></t... |
86ea0e98ce038fc35fa42fa866b200ae597b4f2f6a616f97cbfa7adc4657a33c.png | simple | <table><tr><td>Population</td><td>GO ID</td><td>Gene ontology term</td><td>Genes under GO term</td><td>Related environmental stressor(s)</td><td>Reference</td></tr><tr><td>Kuroilers</td><td>GO:0060584</td><td>Regulation of prostaglandin-endoperoxide synthase activity</td><td>EDN2, EDN1</td><td>Oxidative stress/Pathogen... |
b0a0ca8a28e28a04cb11345d10850bb389359be438496ced9bd1775966bc517f.png | simple | <table><tr><td>Source</td><td><i>F</i> ratio</td><td><i>p</i></td></tr><tr><td>Method</td><td>7.377</td><td>0.013</td></tr><tr><td>Method × group</td><td>0.373</td><td>0.547</td></tr><tr><td>Task</td><td>35.697</td><td>0.000</td></tr><tr><td>Task × group</td><td>0.030</td><td>0.865</td></tr><tr><td>Hemisphere... |
2a30fa2f96392860b4f606ebe018f130370c2e15201d428a8221204f10570aa2.png | simple | <table><tr><td>Solvents</td><td>SC16-Lu</td><td>TC18-Lu</td><td>TC16-Lu</td><td>TC14-Lu</td><td>TC12-Lu</td></tr><tr><td>Acetone</td><td>I</td><td>I</td><td>G (1.5)</td><td>I</td><td>PS</td></tr><tr><td>Aniline</td><td>S</td><td>G (2.0)</td><td>G (2.0)</td><td>G (1.5)</td><td>PS</td></tr><tr><td>Toluene</td><td>PS</td>... |
237a23175dded2f1092b0704a81f7d577ff0b282fd4c554ca3e2ee4c50f9950f.png | complex | <table><tr><td> </td><td>Biocatalyst</td><td>S/B</td><td>RS%</td><td>Xyl%</td><td>Glc%</td><td>Useful results</td></tr><tr><td rowspan="2">1</td><td rowspan="2">TL-xylanase</td><td rowspan="2">3.3</td><td rowspan="2">23.5</td><td rowspan="2">2.26</td><td rowspan="2">8.6</td><td>xylobiose 3.3 g/L</td></tr><tr><td>pentas... |
6a85f3b98cba0a627f1325dfb0b61309c1c29bb51a681a8472acf2782cf3ec27.png | complex | <table><tr><td></td><td>Reason for hysterectomy</td><td></td><td>Number of women with vaginal bleeding</td><td>Odds ratio (95% CI)</td></tr><tr><td rowspan="6">Supracervical abdominal hysterectomy</td><td rowspan="2">Fibroids</td><td>Yes</td><td>16</td><td>0.66 (0.16, 2.71)*</td></tr><tr><td>No</td><td>3</td><td></td><... |
fa25f3bc99b3f07260d9c69edcff8a5bd4c6c036271eaeccba439571587b2366.png | simple | <table><tr><td>Module</td><td>Module hub genes</td><td>Module membership</td><td>LPS log2FC</td><td>DE FDR</td></tr><tr><td>module I</td><td><i>BIRC3</i></td><td>0.97</td><td>1.26</td><td>1.89e-12</td></tr><tr><td>module I</td><td><i>VPS37A</i></td><td>0.95</td><td>0.53</td><td>3.97e-9</td></tr><tr><td>module I</td><td... |
59af4aeaf7b6e182f31bf732260bdabf5b8f6a9632d4b9b1092bdbc32a5063be.png | simple | <table><tr><td>Comparator</td><td>Correlation [95% CI] with UCEIS</td><td>Correlation [95% CI] with Modified Baron Score<sup>a</sup></td></tr><tr><td>Full MCS<sup>+</sup> [including endoscopy]</td><td>0.86 [0.83, 0.88]</td><td>N/A<sup>b</sup></td></tr><tr><td>Partial MCS [excluding endoscopy]</td><td>0.82 [0.79, 0.85]<... |
55265840356d74c790ec41d061e9b8737e4e53ae1a35b01c85cc8dbb0ece513e.png | simple | <table><tr><td></td><td>Vials with FA detectedn (%)</td><td>Vials without FAn (%)</td></tr><tr><td>Infundibulae or surface structures on sections</td><td>376 (72.6)</td><td>94 (18.1)</td></tr><tr><td>No infundibulae or surface structures on sections</td><td>0 (0.0)</td><td>48 (9.3)</td></tr></table> |
58a50a61712fb6bfd8738fb1156ef24cd39df3f1d86c8a8c589abda6d3e77a0e.png | complex | <table><tr><td rowspan="2">Image number</td><td colspan="3">Proposed method (<i>e</i><sub>1</sub>)</td><td colspan="3">Method proposed by Zhang (<i>e</i><sub>2</sub>)</td></tr><tr><td>7</td><td>14</td><td>20</td><td>7</td><td>14</td><td>20</td></tr><tr><td>1</td><td>0.050</td><td>0.021</td><td>0.011</td><td>0.041</td><... |
551074ee442b4da02e38bad7a5d84f1ee6de4f446fa2b31d8604900c81356e38.png | simple | <table><tr><td>Variable</td><td>Number</td><td>%</td></tr><tr><td>Age, mean ± SD</td><td>69.0 ± 10.2</td><td> </td></tr><tr><td>Sex</td><td> </td><td> </td></tr><tr><td> Male</td><td>159</td><td>70.7</td></tr><tr><td> Female</td><td>66</td><td>29.3</td></tr><tr><td>Histology</td><td> </td><td> </td></tr><tr><... |
bd4f98437065e6233f5ba62aeb94c828072e6abcac23bf38b3c52e1a55f9e132.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">Total population</td><td>Consumers only</td><td rowspan="2" colspan="3">Percentiles of intake among consumers</td></tr><tr><td colspan="2">N = 8,861</td><td>n = 2,310</td></tr><tr><td>Gender</td><td>Mean ± SE</td><td>Pct.</td><td>Mean ± SE</td><td>25th ± S... |
ee274ad530b54de04a371851dd62cbb79b7c09d58859f74c56aa2784f614c495.png | complex | <table><tr><td rowspan="2">Sample <sup>a</sup></td><td colspan="5">Molar Composition <sup>b</sup> (Relative %, mol/mol)</td><td colspan="2">Molar Ratio <sup>c</sup></td></tr><tr><td>Ara</td><td>Gal</td><td>Glc</td><td>Xyl</td><td>GlcA</td><td>GlcA/Xyl</td><td>Ara/Xyl</td></tr><tr><td>H<sub>2</sub></td><td>11.25 ± ... |
7c0b26e8fc87352967ca7fb189db6f12c2f889db8749aae5931b62a6cb3c8e56.png | complex | <table><tr><td>Microorganisms</td><td>Isolation Sites</td><td>Applications</td><td>Enzyme</td><td>Reference</td></tr><tr><td><i>Pseudoalteromonas haloplanktis</i></td><td>Antarctica</td><td>Starch conversion; detergent</td><td>Amylase Endo-amylase</td><td>[106]</td></tr><tr><td><i>Zunongwangia profunda</i></td><td>Deep... |
c52942c59800e1e1458fc050a25d1076d68fd853687556befa2079deda66c754.png | simple | <table><tr><td>Indicator</td></tr><tr><td>A Ratio of native Dutch within total population: both parents were born in the Netherlands</td></tr><tr><td>B Ratio of Moroccan origin within total population: person or at least one parent was born in Morocco</td></tr><tr><td>C Ratio of Turkish origin within total population: ... |
965a1204bfa8274f8aa00b0364e36fa0afa7cf10a225ba767755f42f4ddf02cd.png | simple | <table><tr><td></td><td>C</td><td>C + WGP</td><td>HF</td><td>HF + WGP</td></tr><tr><td>Glucose in plasma (mg/dL)</td><td>94.8 ± 1.8</td><td>88.3 ± 3.0</td><td>104.3 ± 2.8*</td><td>91. ± 2.84</td></tr><tr><td>Triglycerides in plasma (mg/mL)</td><td>92.4 ± 6.8</td><td>108.8 ± 4.2</td><td>140... |
81274611a5afc73b18c413e91bb9388a408184e4a0e45b78d874073f03a2ffe3.png | complex | <table><tr><td>Variable</td><td>Group on-pump (<i>n</i> = 146)</td><td>Group off-pump (<i>n</i> = 92)</td><td><i>P</i> Value</td></tr><tr><td colspan="4">Clinical demographics</td></tr><tr><td> Age (y)</td><td>65 ± 8</td><td>63 ± 9</td><td>0.0749</td></tr><tr><td> Female sex</td><td>25 (17.1%)</td><td>12(13.0... |
ea05a163c528a5df64164aa77faff34999192099e3366825cf614106079e98a1.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>Total population</td></tr><tr><td>n = 3807</td></tr><tr><td colspan="2"><i>Gender</i></td></tr><tr><td>Male</td><td>42.1 %</td></tr><tr><td colspan="2"><i>Age (years)</i></td></tr><tr><td>Mean (SD)</td><td>78 (7.68)</td></tr><tr><td>Range</td><td>65–102</td></tr>... |
58a2797d5d03f854f208dd760699e1bd47f9be6ca55471894a18e25d379b5598.png | complex | <table><tr><td></td><td colspan="2">(-)crystal packing</td><td colspan="5">biological interactions(+)</td></tr><tr><td><i>support </i>level</td><td colspan="7">range of support ratios</td></tr><tr><td></td><td>-INF</td><td>-2</td><td>1</td><td>2</td><td>3</td><td>> = 4</td><td>INF</td></tr><tr><td></td><td>-INF</td>... |
ddc696e49d9b5992c46b17678caa479643a03a5daa53e45eb47467be617f10fc.png | simple | <table><tr><td></td><td>Total group (n = 270)</td><td>Subgroup (n = 141)</td></tr><tr><td>Haemoglobin (g/dl)</td><td>13.1 ± 0.9</td><td>13.2 ± 0.9</td></tr><tr><td>Haematocrit (%)</td><td>39.2 ± 2.7</td><td>39.2 ± 2.8</td></tr><tr><td>Mean Corpuscular Volume (fl.)</td><td>87.2 ± 5.0</td><td>86.... |
97c04dff93eb76784078ded1b8bb8a3829687f91425a40324959203c28ab55c4.png | simple | <table><tr><td>Layers</td><td>Attacks</td></tr><tr><td>Physical layer</td><td>Jamming, Node tampering</td></tr><tr><td>Link layer/medium access control</td><td>Collision, exhaustion, and unfairness</td></tr><tr><td>Network and routing layer</td><td>Neglect and greed, homing, misdirection, spoofing, replaying, routing-c... |
d1f36bf7f7510d77cca26057d2ad87d6e41395e7bddd8b31e2e82777e549cac3.png | complex | <table><tr><td></td><td colspan="3">ADC: SUVmax</td><td colspan="3">SQC: SUVmax</td></tr><tr><td>Factor</td><td>Low</td><td>High</td><td><i>P</i>value</td><td>Low</td><td>High</td><td><i>P</i>value</td></tr><tr><td>Pleural invasion</td><td></td><td></td><td>0.027</td><td></td><td></td><td>0.064</td></tr><tr><td> No</td... |
527a53e2defdf81eea993b87a8930c3b658e7fb8b5572d760f1fe9c6cb82fba0.png | complex | <table><tr><td>Accession</td><td>Hydroxycinnamic Acids</td><td>ORAC</td><td>DPPH</td><td>TRC</td><td>NO Inhibition</td></tr><tr><td colspan="6"><i>S. muricatum</i></td></tr><tr><td>37-A</td><td>5</td><td>2</td><td>4</td><td>2</td><td>1</td></tr><tr><td>El Camino</td><td>3</td><td>4</td><td>5</td><td>4</td><td>5</td></t... |
495e09e702afbe3e0dfb4b116e1bd2b9f4e03b612524abe3bb853d84a9867030.png | complex | <table><tr><td rowspan="3">Region</td><td colspan="2">Diseased animals</td><td colspan="2">Apparently healthy animals</td><td colspan="2">Total</td></tr><tr><td>Number of isolates as detected from 16SrRNA</td><td>Positive for <i>SeM</i> gene</td><td>Number of isolates as detected from 16SrRNA</td><td>Positive for <i>Se... |
bc94cfb3fd4f232d6183cda1f276ce61d848770e61e643d28abd232445df8c8f.png | complex | <table><tr><td></td><td>Brain region</td><td>Hemisphere</td><td>NVtxs</td><td>Size (mm<sup>2</sup>)</td><td>X</td><td>Y</td><td>Z</td><td>Max</td><td>CWP</td></tr><tr><td colspan="10"><i>Group comparisons</i></td></tr><tr><td>HC > CD</td><td>Superior temporal gyrus</td><td>R</td><td>338</td><td>154.4</td><td>64</td>... |
79951c92d93fe30330109e0f83dd43ca9294fccade439d1ea6acaa1406a77a35.png | simple | <table><tr><td>NHI Code</td><td>Treatment</td><td>(n = 13,261)</td><td>%</td></tr><tr><td>45010C</td><td>Supportive individual psychotherapy</td><td>2117</td><td>16.0</td></tr><tr><td>45087C</td><td>Re-educative individual psychotherapy-adult</td><td>1578</td><td>11.9</td></tr><tr><td>45088C</td><td>Re-educative indivi... |
d5996ba9872141421ca0a9d147d900e81884028e0e315488486600f4c6de7e6b.png | simple | <table><tr><td></td><td>All patients</td><td>L5/S1 herniations with high iliac crest</td><td>Herniations with scoliosis</td><td>Herniation with calcification</td></tr><tr><td>No. of patients in category</td><td>209</td><td>29</td><td>25</td><td>31</td></tr><tr><td>Excellent or good <i>n</i> (%)</td><td>200 (95.7)</td><... |
f7cf35b15f05e8043bc45a01c19cb44e979746c17e31d2ba029d27cba0dcfb7f.png | simple | <table><tr><td></td><td>RL</td><td>AP</td><td>SI</td><td>Net</td></tr><tr><td>Range</td><td>0-0.85</td><td>0-1.83</td><td>0-1.96</td><td>0.10-2.01</td></tr><tr><td>Average (Right shoulder)</td><td>0.22</td><td>0.36</td><td>0.35</td><td>0.55</td></tr><tr><td>Average (Left shoulder)</td><td>0.26</td><td>0.48</td><td>0.27... |
f958b46f8a326e511cda2f099cf8f878492efd28e18a97d71c44e514f8b57a9e.png | simple | <table><tr><td>F508del</td><td>Sex</td><td>Male</td><td>Female</td><td>Chi-square</td><td>p-value</td></tr><tr><td>-/-</td><td>G/G</td><td>8 (53.3%)</td><td>7 (46.7%)</td><td>0.257</td><td>0.613</td></tr><tr><td> </td><td>G/T and T/T</td><td>15 (45.5%)</td><td>18 (54.5%)</td><td> </td><td> </td></tr><tr><td>F508del/-</... |
442b92b67e2c74cfa7fe57b142ba87a4330d6ad8c08a5db6e2e5bb4dda9fdc06.png | simple | <table><tr><td>Study reference</td><td>Study design</td><td>Reported inclusion/exclusion criteria</td><td>Reported double blind</td><td>Reported clinically-labeled products</td><td>Reported sample power estimation</td><td>Reported adverse events</td><td>Reported study completion ratio</td><td>Overall quality factor sco... |
06df98beaa79f3380b3c6ea699d544542d7765cd2b656287f141207ccefa71f4.png | complex | <table><tr><td rowspan="2"></td><td>With tumor thrombus</td><td rowspan="2"><i>P</i></td><td>Without tumor thrombus</td><td rowspan="2"><i>P</i></td></tr><tr><td>OR(%95 CI)</td><td>OR (%95 CI)</td></tr><tr><td>AFP, ng/mL (> 20 vs. ≤ 20)</td><td>1.1 (0.9, 1.3)</td><td>0.479</td><td>1.1 (0.7, 1.7)</td><td>0.746<... |
9c8962529187e349e7994f2b87f86b0b41eb8255616ab1cd14eb7ed9c8cbfd0a.png | simple | <table><tr><td>No</td><td>A</td><td>B</td><td>C</td><td>D</td><td>extract weight(%)y1</td><td>TTC(%)y2</td><td>score z</td></tr><tr><td>1</td><td>1</td><td>1</td><td>1</td><td>1</td><td>56.76</td><td>22.54</td><td>73.79</td></tr><tr><td>2</td><td>1</td><td>2</td><td>2</td><td>2</td><td>69.10</td><td>24.97</td><td>85.14... |
7156f2cbac62cc874d6f614518f24f61d47efb9f21ced9ef6b4e2cf2ba032c8a.png | simple | <table><tr><td> </td><td><i>WT</i></td><td><i>+/-</i></td><td><i>-/-</i></td></tr><tr><td>Early-stage seizure</td><td>0</td><td>+</td><td>++</td></tr><tr><td>Myoclonic jerks</td><td>0</td><td>+*</td><td>0</td></tr><tr><td>Clonic seizure</td><td>0</td><td>−*</td><td>−−</td></tr><tr><td>Repetitive jumpi... |
4722c45252e375db01143e74ac5724bb201ab176c933675e694358bcd6765b4e.png | simple | <table><tr><td>Up-regulated miRNAs</td><td>Fold-change</td><td><i>P</i></td></tr><tr><td>miR-7</td><td>10.91</td><td>0.005</td></tr><tr><td>miR-196b</td><td>7.67</td><td>0.030</td></tr><tr><td>miR-424</td><td>6.75</td><td>0.008</td></tr><tr><td>miR-18b</td><td>6.67</td><td>0.002</td></tr><tr><td>miR-223</td><td>6.31</t... |
f49227b2874551f92bac8eaed2ceebf875f16ab33ecadffa9b84e9ba23b77a8e.png | complex | <table><tr><td>Statement</td><td>Depression Vignette</td><td>Depression/Suicidal Vignette</td><td>Early Schizophrenia Vignette</td><td>Chronic Schizophrenia Vignette</td></tr><tr><td colspan="5">Person could snap out of the problem</td></tr><tr><td>Australian</td><td>24.7 (21.7%–27.9%)</td><td>22.7 (19.9%–2... |
7b42396457df0300486da1691278c17cd6040b06b61540e1ba3dbf6df8fc78d9.png | complex | <table><tr><td></td><td colspan="2">OR (95% CI)</td></tr><tr><td>Pregnancy outcome (<i>n</i>)</td><td>Unadjusted</td><td>Adjusteda</td></tr><tr><td colspan="3">Term [≥ 37 weeks (923)]</td></tr><tr><td>All preterm [< 37 weeks (101)]</td><td>1.1 (0.6–2.2)</td><td>1.55 (0.7–2.9)</td></tr><tr><td>Moder... |
776dd136dac17669ad393c92072448a01f9d6bf4942a03b643093d4ba21e731f.png | simple | <table><tr><td>Targeted agent</td><td>Chemotherapy</td><td>N</td><td>RR</td><td>PFS (months)</td><td>OS (months)</td><td>Reference</td></tr><tr><td>Cetuximab</td><td>Irinotecan and FU</td><td>49</td><td>42%</td><td>8.6</td><td>16.6</td><td>Kanzler et al. [11]</td></tr><tr><td>Bevacizumab</td><td>Docetaxel, FU and cispl... |
699de5b5f7816bc5c7a164cfc57c66d4e5fe8327e7e69af6d7ee32b898775d82.png | simple | <table><tr><td>ID</td><td>Protein change</td><td><sup>a</sup>Nucleotide change</td><td>Mutation type</td><td><sup>d</sup>PolyPhen-2</td><td><sup>e</sup>SIFT</td><td>Predicted function</td><td>Mutant ratio</td></tr><tr><td>777T</td><td>Y249X</td><td>747T>A</td><td></td><td>nonsense</td><td></td><td>Loss of function</... |
db9027bf58d278ad8dd431bc1c655b901be68339dde06d822d6e0cdc0097581c.png | complex | <table><tr><td rowspan="2"></td><td rowspan="2">Johnsen Score</td><td rowspan="2">Parameters</td><td rowspan="2">Area Under the Curve</td><td rowspan="2">Std. Error</td><td rowspan="2">Asymptotic Sig.</td><td colspan="2">Asymptomic 95% Confidence Interval</td></tr><tr><td>Lower Bound</td><td>Upper Bound</td></tr><tr><t... |
31b57836600699f39bcabda53f8dbd4308c4a580c2f1443f84e6c02a8303a096.png | simple | <table><tr><td>No.</td><td>Age</td><td>Gender</td><td>BSA (m<sup>2</sup>)</td><td>MSKCC risk</td><td>Metastatic sites</td><td>Prior therapy</td></tr><tr><td>1</td><td>70</td><td>Female</td><td>1.298</td><td>Intermediate</td><td>Lung, Lymph nodes</td><td>None</td></tr><tr><td>2</td><td>58</td><td>Female</td><td>1.446</t... |
0e0d453764ad5a7ee457efb2edcf6364da79d706fc79282318356deaa44dcd5b.png | complex | <table><tr><td>Dependent variable: 2009 performance score</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> </td><td>(1)</td><td>(2)</td><td>(3)</td><td>(4)</td><td>(5)</td></tr><tr><td>Private</td><td>−6.212</td><td>−7.030</td><td>−7.026</td><td>−5.548</td><td>−5.311</td... |
1a74357a872ceb0dcdfab8ce96e23c24cb8ce63773b6154e048c1d97e7ff0664.png | simple | <table><tr><td>Sequence</td><td>Faster adaptation for the lens of period 1 (immediate or few hours)</td><td>No difference</td><td>Faster adaptation for the lens of period 2 (immediate or few hours)</td><td>TOTAL</td></tr><tr><td></td><td>N</td><td>N</td><td>N</td><td>N</td></tr><tr><td>New-generation lens then older-ge... |
6adcf219b36f470e2842b66e8dec55166427890746811fc683c6f96202e744c0.png | simple | <table><tr><td>Outcomes</td><td>Lifestyle intervention group n = 27<sup>a</sup></td><td>Close follow-up group n = 27</td><td>p value<sup>b</sup></td></tr><tr><td>Total weight gain (kg)</td><td>11.4 ± 6.0</td><td>13.9 ± 5.1</td><td>NS</td></tr><tr><td>Weight at the end of pregnancy ( kg)</td><td>88.6 ± 14... |
f1417f141fdf08cd0db6ada419c8018ebd70d33db5ace503f4a737fa79788ee7.png | complex | <table><tr><td></td><td>Obese non-diabetic(<i>n</i> = 138)</td><td>Obese diabetic(<i>n</i> = 92)</td><td><i>p</i></td></tr><tr><td colspan="4">Physical and clinical characteristics</td></tr><tr><td>Age (years)</td><td>45.76 ± 9.91</td><td>48.28 ± 8.17</td><td>0.16</td></tr><tr><td>Gender (M/F)</td><td>71/67</... |
75f5e8d72ea49b182ae49c18396ce62655bdb9d12549903a150b7e3628797d23.png | complex | <table><tr><td>Working countries</td><td colspan="2">Health problems suffered during last 12 month</td><td>Total</td></tr><tr><td></td><td>Yes (%)</td><td>No (%)</td><td></td></tr><tr><td>Qatar</td><td>120 (58.5)</td><td>85 (41.5)</td><td>205</td></tr><tr><td>Saudi Arabia</td><td>74 (54.0)</td><td>63 (46.0)</td><td>137... |
94be6a95c5841f0550402775c72a7050e59197c5483342696440c783a2b993d3.png | complex | <table><tr><td></td><td colspan="2">Univariate logistic regression</td><td colspan="2">Multivariable logistic regression</td></tr><tr><td>Variable</td><td>OR (95% CI)</td><td>p-value</td><td>OR (95% CI)</td><td>p-value</td></tr><tr><td>Year</td><td></td><td></td><td></td><td></td></tr><tr><td><i>For every 1-year increa... |
077c32b755ee7c6a0af9540c6cd4c5a237d935fa3b36e03696a0e63ad37e6705.png | simple | <table><tr><td>Studies</td><td><i>n</i></td><td>Procedures</td><td>Mean age ± SD (yr) (min–max)</td><td>Described complication</td><td>% found in each study</td><td>Equivalent % in our cohort</td></tr><tr><td>Sury et al., 1999 [3]</td><td>1155</td><td>MRI</td><td>N/A</td><td>Failure</td><td>5</td><td>2.3</td... |
34ecc799e700053f7eb9f769cd6ad845b2df36e2cbcb4309a7a71f35c78c6969.png | complex | <table><tr><td>Method</td><td>Temporal resolution</td><td>Measure</td><td>Span of interest</td><td colspan="2">General functionality</td><td>Hypothesized emotion-related functionality</td></tr><tr><td>ERP</td><td>Higher (as low as 1 ms)</td><td>Amplitude fluctuations evoked by stimulus</td><td>Short (∼1 s)</td><t... |
c3a2341ab7b7e2eeb89cb55bee65aa60a76bc86b043390bc99fc754ca0f1ad73.png | simple | <table><tr><td></td><td>Odds ratio (95% confidence interval)</td><td>P value</td></tr><tr><td>Age</td><td>1.04 (1.01-1.07)</td><td>0.0022</td></tr><tr><td>BMI</td><td>0.98 (0.93-1.03)</td><td>0.4578</td></tr><tr><td>Female sex</td><td>0.79 (0.47-1.34)</td><td>0.3952</td></tr><tr><td>DR</td><td>1.71 (1.03-2.85)</td><td>... |
4ce9deef60240ee5914d52e6a5479745b486753c21666ce3f346437e04e69e2b.png | simple | <table><tr><td></td><td>Cavus</td><td>Neutral</td><td>Planus</td><td>P-value</td></tr><tr><td>N (female)</td><td>53 (5)</td><td>184 (34)</td><td>711 (133)</td><td></td></tr><tr><td>AHF (mm/kN)</td><td>13.2 ± 7.4</td><td>14.8 ± 7.4</td><td>16.6 ± 7.4</td><td>0.0001 <sup>a,c</sup></td></tr><tr><td>ΔFo... |
59e81cbef37f8ac237f95278ac56a194e3f56361fe6261540d281df1569731db.png | complex | <table><tr><td rowspan="2">Climate model</td><td colspan="3">Seasonal mean temperature (<sup>o</sup>C)</td><td colspan="3">Seasonal cumulated rainfall (mm)</td></tr><tr><td>2030</td><td>2050</td><td>2070</td><td>2030</td><td>2050</td><td>2070</td></tr><tr><td><i>ACCESS1-0</i></td><td>14.3 ± 1.7</td><td>15.1 ±... |
efb3836579f5a42ae21da830136f2589cdc91385e84e03014929167311a79fba.png | complex | <table><tr><td></td><td colspan="2">Changes in WHtR*<sup>1¶</sup></td><td colspan="2">Changes in weight*<sup>2</sup> [kg]</td><td colspan="2">Changes in BMI percentiles*<sup>3</sup></td></tr><tr><td></td><td>(<i>n</i> = 1252)</td><td></td><td>(<i>n</i> = 1251)</td><td></td><td>(<i>n</i> = 1250)</td><td></td></tr><... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.